☆ 4.6 Article

Prognostic value of preoperative circulating tumor cells for hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score analysis

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

Juxian Sun et al.

Summary: Portal vein tumor thrombus (PVTT) is a common factor affecting the prognosis and staging of hepatocellular carcinoma (HCC). The guidelines have been revised to incorporate new treatment options for PVTT, and further research is needed for future strategies in China.

LIVER CANCER (2022)

添加到收藏夹

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Medicine, General & Internal

Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020

Wei Cao et al.

Summary: This study summarized the recent changing profiles of cancer burden worldwide and in China, revealing that breast cancer became the most diagnosed cancer globally in 2020. China accounted for 24% of newly diagnosed cases and 30% of cancer-related deaths worldwide in 2020, with a high cancer mortality rate.

CHINESE MEDICAL JOURNAL (2021)

添加到收藏夹

Article Oncology

The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype

Jing-Jing Yu et al.

Summary: This study found that CTC clusters are common in hepatocellular carcinoma patients and are associated with an aggressive phenotype. CTC clusters can be used as a biomarker to predict the prognosis of HCC patients at each stage of malignancy, providing evidence for formulating more precise treatment strategies.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Review Biology

The multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus

Guoteng Qiu et al.

Summary: Portal vein tumor thrombus (PVTT) is a common complication of hepatocellular carcinoma (HCC) indicating a poor prognosis. Monotherapy is ineffective for HCC-PVTT patients with high recurrence rates. Multidisciplinary management offers hope for improved survival benefits through accurate diagnosis, staging, and implementation of various treatment protocols in the absence of universal guidelines.

BIOSCIENCE TRENDS (2021)

添加到收藏夹

Article Oncology

Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition)

Shuqun Cheng et al.

LIVER CANCER (2020)

添加到收藏夹

Article Oncology

How to Best Detect Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Meeting the Milan Criteria: Gadoxetic Acid-Enhanced MRI versus Contrast-Enhanced CT

Jae Seok Bae et al.

LIVER CANCER (2020)

添加到收藏夹

Review Medicine, General & Internal

Resection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis A systematic review and meta-analysis

Zun-Yi Zhang et al.

MEDICINE (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero et al.

HEPATOLOGY (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle et al.

JOURNAL OF HEPATOLOGY (2018)

添加到收藏夹

Article Oncology

Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma

Jing-jing Yu et al.

BMC CANCER (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies

Po-Hong Liu et al.

SEMINARS IN LIVER DISEASE (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Masao Omata et al.

HEPATOLOGY INTERNATIONAL (2017)

添加到收藏夹

Review Gastroenterology & Hepatology

Surgical treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus

Kazuhiko Sakamoto et al.

HEPATOLOGY RESEARCH (2017)

添加到收藏夹

Article Oncology

Propensity score method: a non-parametric technique to reduce model dependence

Zhongheng Zhang

ANNALS OF TRANSLATIONAL MEDICINE (2017)

添加到收藏夹

Article Oncology

Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection

Yan Zhou et al.

BMC CANCER (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?

Laura F. Ogle et al.

JOURNAL OF HEPATOLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Early dissemination seeds metastasis in breast cancer

Hedayatollah Hosseini et al.

NATURE (2016)

添加到收藏夹

Article Cell Biology

Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis

Jun-Li Fan et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

et al.

JOURNAL OF HEPATOLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

Yun-Fan Sun et al.

HEPATOLOGY (2013)

添加到收藏夹

Article Oncology

Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma

Kornelius Schulze et al.

INTERNATIONAL JOURNAL OF CANCER (2013)

添加到收藏夹

Article Oncology

EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma

Taro Yamashita et al.

CANCER RESEARCH (2008)

添加到收藏夹

Article Oncology

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

Johann S. de Bono et al.

CLINICAL CANCER RESEARCH (2008)

添加到收藏夹

Article Oncology

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

Steven J. Cohen et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

添加到收藏夹

Article Oncology

Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma

XP Chen et al.

ANNALS OF SURGICAL ONCOLOGY (2006)

添加到收藏夹

Article Medicine, General & Internal

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

M Cristofanilli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

添加到收藏夹

Article Pathology

Frequent EpCam protein expression in human carcinomas

PT Went et al.

HUMAN PATHOLOGY (2004)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatocellular carcinoma in Central Europe: prognostic features and survival

M Schoniger-Hekele et al.

GUT (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.